Synthesis and theoretical analysis of interaction from an adamantane-steroid derivative with both COX-1 and COX-2
Author(s) -
FigueroaValverde Lauro,
Francisco Díaz-Cedillo,
RosasNexticapa Marcela,
MateuArmand Virginia,
Patricia Hernandez-Vasquez,
Benitez-Coeto Laura,
Eduardo Pool Gómez,
López-Ramos Maria,
Tomas López-Gutierrez,
Cauich-Carrillo Regina,
BorgesBallote Yaritza,
Cindy Saravia
Publication year - 2019
Publication title -
biointerface research in applied chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.216
H-Index - 11
ISSN - 2069-5837
DOI - 10.33263/briac92.860865
Subject(s) - adamantane , steroid , derivative (finance) , chemistry , enzyme , pharmacology , stereochemistry , biochemistry , medicine , organic chemistry , hormone , financial economics , economics
Several inhibitors of cyclooxygenases (COX-1 and COX-2) have been prepared using different protocols; however, these methods use some reagents that require special conditions. The objective of this study was synthesize a new adamantane-steroid derivative to evaluate their theoretical activity against both COX-1 and COX-2 enzymes using either indomethacin and rofecoxib as controls in a docking method. Theorethical data showed that the adamantane-steroid derivative could have a higher affinity for COX-1; this interaction could produce changes on biological activity of COX-1 enzyme. In onclusion, the theoretical evaluation indicates that this steroid-derivative could be a good prospect as an inhibitor of COX-1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom